Provided by Tiger Fintech (Singapore) Pte. Ltd.

Clearside Biomedical

0.4972
-0.0416-7.72%
Post-market: 0.49720.00000.00%19:59 EDT
Volume:2.37M
Turnover:1.23M
Market Cap:38.64M
PE:-1.22
High:0.5470
Open:0.5400
Low:0.4800
Close:0.5388
Loading ...

Clearside Biomedical Inc. Announces Date for Special Stockholders Meeting

Reuters
·
5 hours ago

BRIEF-Clearside Biomedical Announces Approval Of Xipere® Suprachoroidal Treatment For Uveitic Macular Edema In Canada

Reuters
·
23 Jul

Clearside Biomedical Shares Fall After Analyst Downgrades

MT Newswires Live
·
19 Jul

Chardan Downgrades Clearside Biomedical to Neutral From Buy, Withdraws $6 Price Target

MT Newswires Live
·
18 Jul

Clearside Biomedical downgraded to Neutral from Buy at Chardan

TIPRANKS
·
18 Jul

Clearside Biomedical Downgraded to Hold Amid Strategic and Financial Uncertainties

TIPRANKS
·
18 Jul

Citizens JMP downgrades Clearside Biomedical (CLSD) to a Hold

TIPRANKS
·
18 Jul

Clearside Biomedical downgraded to Hold from Buy at JonesResearch

TIPRANKS
·
17 Jul

Hold Rating for Clearside Biomedical Amid Strategic Uncertainty and Financial Constraints

TIPRANKS
·
17 Jul

Clearside Biomedical Announces Plan To Explore Strategic Alternatives To Advance Its Proprietary Suprachoroidal Space (Scs®) Delivery Platform And Promising Ophthalmology Pipeline

Reuters
·
17 Jul

BRIEF-Clearside Biomedical Inc - All Employees To Transition To Consulting Roles - SEC Filing

Reuters
·
17 Jul

Clearside to Shift Staff to Consultants, Halt R&D, as It Seeks Strategic Alternatives

Dow Jones
·
17 Jul

Clearside Biomedical transitions all employees to consulting roles

TIPRANKS
·
17 Jul

Clearside Biomedical to explore strategic alternatives to advance SCS platform

TIPRANKS
·
17 Jul

Clearside Biomedical Inc. Conducted Annual Stockholders Meeting

Reuters
·
31 May

Clearside Biomedical Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
23 May

Clearside Biomedical price target lowered to $5 from $6 at H.C. Wainwright

TIPRANKS
·
23 May

Clearside Biomedical Price Target Maintained With a $5.00/Share by JMP Securities

Dow Jones
·
17 May

Citizens JMP Keeps Their Buy Rating on Clearside Biomedical (CLSD)

TIPRANKS
·
16 May

Clearside Biomedical Reports Q1 2025 Financial Progress

TIPRANKS
·
16 May